Trial Profile
Is "Beta Cell Rest" by Insulin Treatment Beneficial Compared to State-of-the Art Enhancers of Insulin Secretion in Preserving Beta Cell Function in Subjects With Latent Autoimmune Diabetes of the Adult (LADA).
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Insulin suspension isophane (Primary) ; Sitagliptin (Primary) ; Metformin; Repaglinide
- Indications Latent autoimmune diabetes in adults
- Focus Therapeutic Use
- 18 Mar 2019 Status changed from active, no longer recruiting to completed.
- 05 Oct 2018 Results (n=61) presented at the 54th Annual Meeting of the European Association for the Study of Diabetes
- 18 Aug 2017 Planned End Date changed from 1 Mar 2017 to 1 Dec 2018.